| Literature DB >> 25408552 |
Stefan J Hermans1, David B Ascher, Nancy C Hancock, Jessica K Holien, Belinda J Michell, Siew Yeen Chai, Craig J Morton, Michael W Parker.
Abstract
Insulin-regulated aminopeptidase (IRAP or oxytocinase) is a membrane-bound zinc-metallopeptidase that cleaves neuroactive peptides in the brain and produces memory enhancing effects when inhibited. We have determined the crystal structure of human IRAP revealing a closed, four domain arrangement with a large, mostly buried cavity abutting the active site. The structure reveals that the GAMEN exopeptidase loop adopts a very different conformation from other aminopeptidases, thus explaining IRAP's unique specificity for cyclic peptides such as oxytocin and vasopressin. Computational docking of a series of IRAP-specific cognitive enhancers into the crystal structure provides a molecular basis for their structure-activity relationships and demonstrates that the structure will be a powerful tool in the development of new classes of cognitive enhancers for treating a variety of memory disorders such as Alzheimer's disease.Entities:
Keywords: Alzheimer's disease; aminopeptidase; catalysis; computational modeling; crystallography; cyclic peptide; insulin signaling; memory enhancers
Mesh:
Substances:
Year: 2014 PMID: 25408552 PMCID: PMC4315657 DOI: 10.1002/pro.2604
Source DB: PubMed Journal: Protein Sci ISSN: 0961-8368 Impact factor: 6.725